On-Demand CME Videos
'5 in 5' Five Tips to Improve Clinical Care for Diverse Patient Populations: An Online Activity
About
This activity is supported by educational grants from Amgen, Galderma, Incyte, LEO Pharma, Lilly and L'Oreal.
Once you have completed this activity, please download "Current and Future Topical and Systemic Options for Inflammatory Dermatologic Conditions: Therapeutic Landscape" to help you when you are treating diverse patients in your practice.
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
May 24, 2024
May 24, 2025
Learning Objectives
At the completion of this activity, participants should be better able to:
Describe how to assess patients with diverse cultural backgrounds, SOC, and sexual orientation
Review treatment options for common dermatoses seen in diverse patient populations
Employ strategies to effectively communicate with patients with diverse cultural backgrounds, SOC, and sexual orientation
Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
Mona Shahriari, MD
Dermatologist, Yale University School of Medicine
Central CT Dermatology
Cromwell, CT
Susan Taylor, MD
Bernett L. Johnson Endowed Professor
Director, Skin of Color Research Fellowship
Vice Chair for Diversity, Equity and Inclusion, Department of Dermatology
Perelman School of Medicine at the University of Pennsylvania
Founder, Skin of Color Society
Philadelphia, PA
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Grant/Research Support: AbbVie, Dermira, Cara, Dermavant, Novartis, Union
Consultant: Abbvie, BMS, Dermavant, Leo, Lilly, Sanofi, Regeneron, UCB
Speakers’ Bureau or Honoraria: Abbvie, BMS, Lilly, Leo, Janssen, Dermavant
Advisory Board: AbbVie, Avita Medical, Beiersdorf, Biorez (past), Eli Lilly, EPI Health, Evolus, Galderma, Hugel America, Incyte, Johnson & Johnson, L'Oreal USA, Medscape, Pfizer, Scientis US, UCB, Vichy Laboratoires Grant/Research Support: Allergan Aesthetics, Concert Pharmaceuticals/Sun Pharma, Croma Pharma GmbH, Eli Lilly, Pfizer Consultant: Arcutis, Armis Scientific, Beiersdorf, Bristol Myers Squibb, Cara Therapeutics, Dior, GloGetter, Piction Health, Sanofi Speakers’ Bureau or Honoraria: Beiersdorf, Medscape, MJH Lifesciences Royalty: McGraw Hill Publishing Ownership Interest (privately held): Armis Scientific, GloGetter, Piction Health Other Financial Benefit: Mercer Strategies LLC
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.